184 related articles for article (PubMed ID: 37220155)
1. Effects of adipocyte-conditioned cell culture media on S1P treatment of human triple-negative breast cancer cells.
Wu X; Wabitsch M; Yang J; Sakharkar MK
PLoS One; 2023; 18(5):e0286111. PubMed ID: 37220155
[TBL] [Abstract][Full Text] [Related]
2. Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes.
Wu X; Sakharkar MK; Wabitsch M; Yang J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291440
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the antitumor activity of sphingosine-1-phosphate against human triple-negative breast cancer cells with basal-like morphology.
Abuhussein O; Yang J
Invest New Drugs; 2020 Oct; 38(5):1316-1325. PubMed ID: 32060788
[TBL] [Abstract][Full Text] [Related]
4. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
Maiti A; Takabe K; Hait NC
Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
[TBL] [Abstract][Full Text] [Related]
5. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
6. EGCG Prevents the Onset of an Inflammatory and Cancer-Associated Adipocyte-like Phenotype in Adipose-Derived Mesenchymal Stem/Stromal Cells in Response to the Triple-Negative Breast Cancer Secretome.
Gonzalez Suarez N; Fernandez-Marrero Y; Torabidastgerdooei S; Annabi B
Nutrients; 2022 Mar; 14(5):. PubMed ID: 35268073
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes.
Ito S; Iwaki S; Koike K; Yuda Y; Nagasaki A; Ohkawa R; Yatomi Y; Furumoto T; Tsutsui H; Sobel BE; Fujii S
Coron Artery Dis; 2013 Dec; 24(8):642-50. PubMed ID: 24212262
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis.
Tsuchida J; Nagahashi M; Nakajima M; Moro K; Tatsuda K; Ramanathan R; Takabe K; Wakai T
J Surg Res; 2016 Sep; 205(1):85-94. PubMed ID: 27621003
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-phosphate signaling: A novel target for simultaneous adjuvant treatment of triple negative breast cancer and chemotherapy-induced neuropathic pain.
Singh SK; Spiegel S
Adv Biol Regul; 2020 Jan; 75():100670. PubMed ID: 31708456
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Effect between Sphingosine-1-Phosphate and Chemotherapy Drugs against Human Brain-metastasized Breast Cancer MDA-MB-361 cells.
Sultan A; Ling B; Zhang H; Ma B; Michel D; Alcorn J; Yang J
J Cancer; 2013; 4(4):315-9. PubMed ID: 23569464
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hypoxia-inducible factor functions in the nucleus by sphingosine-1-phosphate.
Hait NC; Maiti A; Xu P; Qi Q; Kawaguchi T; Okano M; Takabe K; Yan L; Luo C
FASEB J; 2020 Mar; 34(3):4293-4310. PubMed ID: 32017264
[TBL] [Abstract][Full Text] [Related]
12. EGCG Inhibits Adipose-Derived Mesenchymal Stem Cells Differentiation into Adipocytes and Prevents a STAT3-Mediated Paracrine Oncogenic Control of Triple-Negative Breast Cancer Cell Invasive Phenotype.
Gonzalez Suarez N; Rodriguez Torres S; Ouanouki A; El Cheikh-Hussein L; Annabi B
Molecules; 2021 Mar; 26(6):. PubMed ID: 33801973
[TBL] [Abstract][Full Text] [Related]
13. Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis.
Nagahashi M; Yamada A; Katsuta E; Aoyagi T; Huang WC; Terracina KP; Hait NC; Allegood JC; Tsuchida J; Yuza K; Nakajima M; Abe M; Sakimura K; Milstien S; Wakai T; Spiegel S; Takabe K
Cancer Res; 2018 Apr; 78(7):1713-1725. PubMed ID: 29351902
[TBL] [Abstract][Full Text] [Related]
14. The Adipose Mesenchymal Stem Cell Secretome Inhibits Inflammatory Responses of Microglia: Evidence for an Involvement of Sphingosine-1-Phosphate Signalling.
Marfia G; Navone SE; Hadi LA; Paroni M; Berno V; Beretta M; Gualtierotti R; Ingegnoli F; Levi V; Miozzo M; Geginat J; Fassina L; Rampini P; Tremolada C; Riboni L; Campanella R
Stem Cells Dev; 2016 Jul; 25(14):1095-107. PubMed ID: 27217090
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast-derived sphingosine 1-phosphate to induce proliferation and confer resistance to therapeutics to bone metastasis-derived prostate cancer cells.
Brizuela L; Martin C; Jeannot P; Ader I; Gstalder C; Andrieu G; Bocquet M; Laffosse JM; Gomez-Brouchet A; Malavaud B; Sabbadini RA; Cuvillier O
Mol Oncol; 2014 Oct; 8(7):1181-95. PubMed ID: 24768038
[TBL] [Abstract][Full Text] [Related]
16. Interstitial Fluid Sphingosine-1-Phosphate in Murine Mammary Gland and Cancer and Human Breast Tissue and Cancer Determined by Novel Methods.
Nagahashi M; Yamada A; Miyazaki H; Allegood JC; Tsuchida J; Aoyagi T; Huang WC; Terracina KP; Adams BJ; Rashid OM; Milstien S; Wakai T; Spiegel S; Takabe K
J Mammary Gland Biol Neoplasia; 2016 Jun; 21(1-2):9-17. PubMed ID: 27194029
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway.
Li J; Song Z; Wang Y; Yin Y; Liu Y; Yuan R; Nan X
Tumour Biol; 2016 Aug; 37(8):10587-93. PubMed ID: 26857281
[TBL] [Abstract][Full Text] [Related]
18. ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer.
Yamada A; Nagahashi M; Aoyagi T; Huang WC; Lima S; Hait NC; Maiti A; Kida K; Terracina KP; Miyazaki H; Ishikawa T; Endo I; Waters MR; Qi Q; Yan L; Milstien S; Spiegel S; Takabe K
Mol Cancer Res; 2018 Jun; 16(6):1059-1070. PubMed ID: 29523764
[TBL] [Abstract][Full Text] [Related]
19. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC.
Liu Q; Dong HT; Zhao T; Yao F; Xu Y; Chen B; Wu Y; Jin F; Xing P
Endocr Relat Cancer; 2022 Feb; 29(3):139-149. PubMed ID: 34935631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
